Clinical trials

  • EFINOPEGDUTIDE for Metabolic dysfunction-associated steatohepatitis (MASH) | Compensated cirrhosis
  • Clinical trial in Metastatic or locally advanced solid tumors|Lung cancer|Head and neck cancer|Colon cancer|Gastric cancer|Esophageal cancer|Breast cancer|Ovarian cancer|Fallopian tube cancer|Primary peritoneal high-grade serous carcinoma
  • SUB197397 for Non-small cell lung cancer (KRAS G12C-positive) | Advanced or metastatic non-small cell lung cancer
  • AMLITELIMAB for Coeliac disease | Non-responsive celiac disease
  • Pembrolizumab for Classical Hodgkin lymphoma | Primary mediastinal large B-cell lymphoma
  • NECVAX-NEO1 for Advanced solid tumors
  • U3-1402 for Non-small cell lung cancer | Metastatic or unresectable non-small cell lung cancer
  • Pazopanib for Glioblastoma
  • TRASTUZUMAB DERUXTECAN for HER2-positive metastatic breast cancer | Metastatic breast cancer
  • ASCIMINIB HYDROCHLORIDE for Chronic Myeloid Leukemia
  • EPLONTERSEN for Hereditary transthyretin-mediated amyloid polyneuropathy (hATTR-PN) | Familial amyloid polyneuropathy
  • Tamoxifen for Myelofibrosis